Leukemia Research
Volume 26, Issue 8 , Pages 771-774, August 2002

Lymphoid blastic crisis of chronic myelogenous leukaemia with inv(16)(p13;q22)

  • Kazuya Tsuboi

      Affiliations

    • Second Department of Internal Medicine, Nagoya City University Medical School, Mizuho-ku, Nagoya 467-8601, Japan
    • Department of Internal Medicine, Division of Haematology, Aichi Medical University, Nagakute-cho, Aichi-gun, Aichi 480-1195, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-561-62-3311; fax: +81-561-63-3401
  • ,
  • Hirokazu Komatsu

      Affiliations

    • Second Department of Internal Medicine, Nagoya City University Medical School, Mizuho-ku, Nagoya 467-8601, Japan
  • ,
  • Hiroshi Miwa

      Affiliations

    • Department of Internal Medicine, Division of Haematology, Aichi Medical University, Nagakute-cho, Aichi-gun, Aichi 480-1195, Japan
  • ,
  • Shinsuke Iida

      Affiliations

    • Second Department of Internal Medicine, Nagoya City University Medical School, Mizuho-ku, Nagoya 467-8601, Japan
  • ,
  • Shogo Banno

      Affiliations

    • Second Department of Internal Medicine, Nagoya City University Medical School, Mizuho-ku, Nagoya 467-8601, Japan
  • ,
  • Atsushi Wakita

      Affiliations

    • Second Department of Internal Medicine, Nagoya City University Medical School, Mizuho-ku, Nagoya 467-8601, Japan
  • ,
  • Masakazu Nitta

      Affiliations

    • Department of Internal Medicine, Division of Haematology, Aichi Medical University, Nagakute-cho, Aichi-gun, Aichi 480-1195, Japan
  • ,
  • Ryuzo Ueda

      Affiliations

    • Second Department of Internal Medicine, Nagoya City University Medical School, Mizuho-ku, Nagoya 467-8601, Japan

Received 20 September 2001; accepted 1 November 2001.

Abstract 

We report a case of chronic myelogeneous leukaemia (CML) in B-lineage lymphoid blastic crisis (BC) having chromosome abnormality, inv(16)(p13;q22) in addition to Philadelphia chromosome, in 20/20 marrow metaphase. Inv(16)(p13;q22) was not observed in cells of chronic phase or accelerate phase. Abnormalities of chromosome 16, including inv(16)(p13;q22), del(16)(q22) and t(16;16)(p13;q22), have been reported mostly in acute myelomonocytic leukaemia (AML), (FAB M4-Eo), and some in CML–BC and myelodysplastic syndrome (MDS) cases. Most of the cases showed increase of myelomonocytic components and abnormal eosinophils with dysplastic granules in the bone marrow (BM). However, our case was diagnosed as lymphoid BC without increase of myelomonocytic components, although some abnormal eosinophilia was seen. To date, lymphoid BC of CML having inv(16)(p13;q22) abnormality has not been reported. The case presented here could be a clue to understand the pathophysiology of inv(16)(p13;q22) leukaemia.

Lymphoid crisis, CML, Inv(16)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(01)00199-0

Leukemia Research
Volume 26, Issue 8 , Pages 771-774, August 2002